RxDoctor Payments DataLook up a doctor →

Alison Laflower, APRN

Adult Health · Indianapolis, INNPI 1114157633

Payments from drug & device makers

$13,224in general payments, 2019–2025

Across 544 payments — averaging $24.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1K
  • Johnson & Johnson$1K
  • E.r. Squibb & Sons, L.L.C.$942
  • Pfizer$745
  • AstraZeneca$718
  • Merck$687
  • plus $8K from 50 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis95$1,372
Johnson & Johnson(2 entities)36$1,218
E.r. Squibb & Sons, L.L.C.20$942
Pfizer35$745
AstraZeneca(2 entities)28$718
Merck31$687
Eisai Inc.22$630
Incyte Corporation16$611
Sanofi20$424
Bristol Myers Squibb25$369
Daiichi Sankyo Inc.19$351
AbbVie13$348
Tempus AI, Inc5$296
Exelixis Inc.12$295
Bayer10$291
Amgen11$288
Gilead(2 entities)14$280
Novocure Inc.3$264
Lilly USA, LLC10$249
GSK13$246
Beone Medicines USA, Inc.3$220
Genentech USA, Inc.14$212
Adaptive Biotechnologies Corporation4$176
Pharmacosmos Therapeutics Inc.4$174
Seagen Inc.9$168
Takeda Pharmaceuticals U.S.A., Inc.9$166
Pharmacyclics LLC, An Abbvie Company9$156
Syndax Pharmaceuticals, Inc.1$141
Stemline Therapeutics Inc.1$124
AVEO Pharmaceuticals, Inc.1$99
Pharmaessentia USA Corporation4$89
Servier Pharmaceuticals LLC4$82
Array Biopharma Inc5$82
Sobi, Inc4$60
Regeneron Healthcare Solutions, Inc.2$57
Morphosys, US Inc.3$55
Jazz Pharmaceuticals Inc.2$54
Rigel Pharmaceuticals, Inc.2$48
Genmab U.S., Inc.3$43
Recordati_rare_diseases_inc.2$40
Taiho Oncology, Inc.2$37
Astellas Pharma US Inc2$37
Boehringer Ingelheim2$36
Dova Pharmaceuticals2$35
Mirati Therapeutics, Inc.1$24
Geron Corporation1$24
Deciphera Pharmaceuticals Inc.1$20
EMD Serono, Inc.1$19
Ipsen Biopharmaceuticals, Inc1$18
Blueprint Medicines Corporation1$16
CTI Biopharma Corp.1$16
Acrotech Biopharma Inc.1$15
Beigene USA, Inc.1$15
Organox Ltd1$15
Legend Biotech USA Inc.1$14
Iovance Biotherapeutics, Inc.1$13

How this compares

$13,224 in reported general payments places this provider in the 95th percentile of 391 adult health providers in Indiana.

See all adult health providers in Indiana →

Medicare billing

Part B allowed, 2024
$65,325
Medicare patients
290
Services billed
2,122

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Indianapolis

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →